Chakma Justin

ARS Pharmaceuticals, Inc. · Chief Business Officer

Chakma Justin is listed in public filings as officer: Chief Business Officer. This Chakma Justin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include ARS Pharmaceuticals, Inc. (SPRY). Investors use Chakma Justin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
ARS Pharmaceuticals, Inc.SPRY	$2.8M240k shares	Grant / ExerciseJan 2, 2026	$2.8M240k shares	$11.49	--

Insider Trades History

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
ARS Pharmaceuticals, Inc.SPRY	$0136.4k shares	SellNov 12, 2025	$1.2M136.4k shares	$8.86	--
ARS Pharmaceuticals, Inc.SPRY	$1.2M136.4k shares	SellNov 12, 2025	$267.4K30k shares	$8.91	--
ARS Pharmaceuticals, Inc.SPRY	$75k89k shares	Grant / ExerciseNov 12, 2025	$25.2K30k shares	$0.84	--
ARS Pharmaceuticals, Inc.SPRY	$2.9M274.1k shares	Grant / ExerciseJan 2, 2025	$2.9M274.1k shares	$10.71	--
ARS Pharmaceuticals, Inc.SPRY	$1.6M136.4k shares	SellDec 13, 2024	$329.0K27.3k shares	$12.06	--
ARS Pharmaceuticals, Inc.SPRY	$80k55.5k shares	Grant / ExerciseDec 13, 2024	$39.3K27.3k shares	$1.44	--
ARS Pharmaceuticals, Inc.SPRY	$1.7M136.4k shares	SellDec 12, 2024	$1.4M117.3k shares	$12.27	--
ARS Pharmaceuticals, Inc.SPRY	$100k119k shares	Grant / ExerciseDec 12, 2024	$98.6K117.3k shares	$0.84	--
ARS Pharmaceuticals, Inc.SPRY	$1.8M136.4k shares	SellDec 10, 2024	$657.6K50k shares	$13.15	--
ARS Pharmaceuticals, Inc.SPRY	$050k shares	Grant / ExerciseDec 10, 2024	$42.0K50k shares	$0.84	--
ARS Pharmaceuticals, Inc.SPRY	$1.9M136.4k shares	SellDec 6, 2024	$711.6K50k shares	$14.23	--
ARS Pharmaceuticals, Inc.SPRY	$42k50k shares	Grant / ExerciseDec 6, 2024	$42.0K50k shares	$0.84	--
ARS Pharmaceuticals, Inc.SPRY	$1.9M136.4k shares	SellDec 5, 2024	$701.6K49.6k shares	$14.13	--
ARS Pharmaceuticals, Inc.SPRY	$84k100k shares	Grant / ExerciseDec 5, 2024	$41.7K49.6k shares	$0.84	--
ARS Pharmaceuticals, Inc.SPRY	$1.9M136.4k shares	SellDec 4, 2024	$627.9K45k shares	$13.95	--
ARS Pharmaceuticals, Inc.SPRY	$126k149.6k shares	Grant / ExerciseDec 4, 2024	$37.8K45k shares	$0.84	--
ARS Pharmaceuticals, Inc.SPRY	$1.8M136.4k shares	SellDec 3, 2024	$593.4K45k shares	$13.19	--
ARS Pharmaceuticals, Inc.SPRY	$03.3k shares	Grant / ExerciseDec 3, 2024	$2.7K3.3k shares	$0.84	--
ARS Pharmaceuticals, Inc.SPRY	$152k181.4k shares	Grant / ExerciseDec 3, 2024	$35.1K41.7k shares	$0.84	--
ARS Pharmaceuticals, Inc.SPRY	$1.9M136.4k shares	SellDec 2, 2024	$615.2K45k shares	$13.67	--
ARS Pharmaceuticals, Inc.SPRY	$2.7k3.3k shares	Grant / ExerciseDec 2, 2024	$37.8K45k shares	$0.84	--
ARS Pharmaceuticals, Inc.SPRY	$2.0M136.4k shares	SellNov 27, 2024	$359.8K25k shares	$14.39	--
ARS Pharmaceuticals, Inc.SPRY	$2.3M161.4k shares	SellNov 26, 2024	$592.6K42.2k shares	$14.05	--
ARS Pharmaceuticals, Inc.SPRY	$2.9M203.6k shares	SellNov 25, 2024	$459.4K32.8k shares	$14.00	--